MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/sdi.13106

Медицинская библиотека · Seminars in dialysis · 2022

Sarcopenia and cardiovascular risk indices: Its impact on cardiovascular events and mortality in dialysis patients.

Baltacı Mehmet Akif, Atmis Volkan, Metin Yavuz, Aktar Merve, Eren Sayeste Akkan, Sengul Sule, Ates Kenan, Kutlay Sim

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Sarcopenia is a common complication in end-stage renal disease. Low muscle strength and muscle mass are risk factors for cardiovascular disease and mortality in patients undergoing dialysis. We studied the relation between sarcopenia and pre-atherosclerotic markers and its effect on cardiovascular events and death in dialysis patients.

METHODS

We measured muscle strength, muscle mass, carotid intima-media thickness, and pulse wave velocity in 106 patients. Sarcopenia was diagnosed according to the EWGSOP-2 suggestions. Patients with low muscle strength and low muscle mass were considered sarcopenic. The follow-up period for cardiovascular events and mortality was 24 months.

RESULTS

The mean age and dialysis duration were 57.4 ± 16.6 and 6.5 ± 4.9 years, respectively. Of all patients, 53 (50%) were male and 70 (66%) were on hemodialysis treatment. Sarcopenia and low muscle strength were seen in 47.1% and 88.7%, respectively. Hemodialysis patients were more likely to be sarcopenic than peritoneal dialysis patients (p = 0.001). Ferritin and Kt/V levels were higher, and body mass index was lower significantly in sarcopenic patients (p < 0.001). There was no significant difference in carotid intima-media thickness and pulse wave velocity measurements between the groups (p = 0.62 and p = 0.68, respectively). There was no statistically significant difference in cardiovascular events and mortality in cases with and without sarcopenia (p = 0.43 and p = 0.17, respectively).

CONCLUSION

There was no association between sarcopenia and pre-atherosclerotic markers, cardiovascular events, and all-cause mortality in dialysis patients. Techniques to detect low muscle strength and muscle mass need standardization, and new specific cut-off levels must be defined for dialysis patients.

Для цитирования: Baltacı Mehmet Akif, Atmis Volkan, Metin Yavuz, Aktar Merve, Eren Sayeste Akkan, Sengul Sule, Ates Kenan, Kutlay Sim. Sarcopenia and cardiovascular risk indices: Its impact on cardiovascular events and mortality in dialysis patients.. Seminars in dialysis. 2022. DOI: 10.1111/sdi.13106.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.